Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators. Colleoni M, et al. Among authors: kamby c. Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17. Lancet Oncol. 2018. PMID: 29158011 Clinical Trial.
Antiangiogenic therapy for breast cancer.
Nielsen DL, Andersson M, Andersen JL, Kamby C. Nielsen DL, et al. Among authors: kamby c. Breast Cancer Res. 2010;12(5):209. doi: 10.1186/bcr2642. Epub 2010 Sep 29. Breast Cancer Res. 2010. PMID: 21067536 Free PMC article. Review.
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).
Andersen J, Kamby C, Ejlertsen B, Cold S, Ewertz M, Jacobsen EH, Philip P, Møller KA, Jensen D, Møller S. Andersen J, et al. Among authors: kamby c. Acta Oncol. 2008;47(4):718-24. doi: 10.1080/02841860802014882. Acta Oncol. 2008. PMID: 18465340 Clinical Trial.
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
Kristensen B, Ejlertsen B, Mouridsen HT, Jensen MB, Andersen J, Bjerregaard B, Cold S, Edlund P, Ewertz M, Kamby C, Lindman H, Nordenskjöld B, Bergh J. Kristensen B, et al. Among authors: kamby c. Acta Oncol. 2008;47(4):740-6. doi: 10.1080/02841860801964988. Acta Oncol. 2008. PMID: 18465343 Clinical Trial.
[Loco-regional recurrence of breast cancer].
Nielsen HM, Kamby C. Nielsen HM, et al. Among authors: kamby c. Ugeskr Laeger. 2007 Sep 10;169(37):3093-6. Ugeskr Laeger. 2007. PMID: 17877957 Danish.
Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.
Nielsen DL, Bjerre KD, Jakobsen EH, Cold S, Stenbygaard L, Sørensen PG, Kamby C, Møller S, Jørgensen CL, Andersson M. Nielsen DL, et al. Among authors: kamby c. J Clin Oncol. 2011 Dec 20;29(36):4748-54. doi: 10.1200/JCO.2010.33.9507. Epub 2011 Nov 14. J Clin Oncol. 2011. PMID: 22084374 Clinical Trial.
108 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page